Cite
HARVARD Citation
Kaye, K. et al. (n.d.). Clinical Outcomes of Serious Infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) in TANGO II, a Phase 3, Randomized, Multi-National, Open-Label Trial of Meropenem-Vaborbactam (M-V) Vs. Best Available Therapy (BAT). Open forum infectious diseases. pp. S534-S535. [Online].